RT is characterised by higher molecular complexity than CLL and commonly involve lesions of suppression regulators (deletion and/or mutation of TP53), cell cycle (loss of CDKN2A), and cell proliferation (NOTCH1 mutation, MYC activation) [11]. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.